AI Psychosis and Psychedelics: A Risky Combination
“AI psychosis” isn’t a formal diagnosis, but people use the term to describe when AI interactions seem to intensify paranoia,…
Read ArticlePlease do not resubmit. This page will update automatically once your donation is confirmed.
Project:
Amount:
Type:
We sincerely appreciate your generous donation to Entheology Project Inc. As a 501(c)(3) public charity (EIN 88-1953133), your donation is tax-deductible to the extent allowed by law. You will receive an email confirmation for your records, which can be used for tax purposes. Your support helps us continue our mission and make a meaningful impact!
Return to Support a Project | Share This Project
Best Regards,
EP Support
help@entheologyproject.org
No payment was recorded. Please review your payment information or try another method.
Error: Contact form not found.
Thoughtful preparation cannot eliminate risk, but it can help people seeking psychedelic therapy (Seekers) to identify concerns earlier, set realistic expectations, and connect with appropriate human support. Entheology Project combines education, practical risk-awareness tools, and technology that helps psychedelic professionals spend less time on administrative work and more time supporting Seekers.
EntheoDNA is an at-home pharmacogenomic test that raises awareness of selected inherited factors related to metabolism, sensitivity, receptor pathways, and other biological tendencies. It provides sensitivity information related to psilocybin, LSD, MDMA, pure DMT, 5-MeO-DMT, ketamine, ibogaine, mescaline, Salvia divinorum, and cannabis.
Results can help Seekers identify biological factors to discuss with a qualified professional, but they do not predict an experience, recommend a dose, provide medical clearance, or guarantee safety.
Before traveling long distances and committing significant money to a psychedelic retreat center or clinic, understand what deserves attention. Psychedelic Ready brings medications, physical health, emotional wellbeing, past experiences, preparation, support, and the entheogen being considered into one clear, evidence-informed risk-awareness report.
It is more than a report. Entheogens 101 builds a shared foundation in expectations, set, setting, support, and integration, and Theo AI explains any part of your results in plain language. When EntheoDNA results are available, they can be included to add biological context.
You decide who can see your report, and you can remove access at any time. If a coach or retreat center invited you, sharing it lets them prepare with you instead of starting from scratch.
Coaches and retreat centers can invite their clients from a shared workspace. Each client completes a structured assessment, works through Entheogens 101 at their own pace, and chooses to share the finished report back with you.
Registering your center or practice costs nothing and there is no commission, because each Seeker purchases their own assessment. What you get is deep insight into their preparation process: medications and possible interactions, physical health, emotional wellbeing, past experiences, support and setting, the entheogen they are considering, their progress through the coursework, and what information is still missing. You and your client read the same report, and your team keeps its own screening, judgment, and admission decisions.
Miraculix portable tests can help estimate the amount of a target substance in a sample when used according to the product instructions. Testing can reduce uncertainty, but it cannot guarantee purity, legality, safety, or how a person will respond.
LIMS provides privacy-focused access to participating laboratories for sample testing, status tracking, and online Certificates of Analysis. Results can provide useful information about the submitted sample within the limits of the selected analysis, but they do not certify that a substance is safe to possess, consume, or use.
“AI psychosis” isn’t a formal diagnosis, but people use the term to describe when AI interactions seem to intensify paranoia,…
Read Article
This is a watershed moment for psychedelic medicine. Eli Lilly’s acquisition of AtaiBeckley for up to $3.8 billion sends a…
Read Article
Know before you dose. Knowing your sensitivities before the trip. As scientific interest in psychedelic-assisted therapies continues to grow, one…
Read ArticleEach of our initiatives has its own needs — and multiple ways you can contribute. Choose a project to volunteer your skills, make a project-specific donation, or explore a philanthropic partnership.